OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunogenicity and Safety of COVID-19 Vaccines among People Living with HIV: A Systematic Review and Meta-Analysis
Liangyu Kang, Weijing Shang, Peng Gao, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1569-1569
Open Access | Times Cited: 21

Showing 21 citing articles:

A systematic review and meta-analysis of the global prevalence and determinants of COVID-19 vaccine acceptance and uptake in people living with HIV
Sahabi Kabir Sulaiman, Muhammad Sale Musa, Fatimah I. Tsiga-Ahmed, et al.
Nature Human Behaviour (2023) Vol. 8, Iss. 1, pp. 100-114
Open Access | Times Cited: 18

The effect of HIV on COVID-19 vaccine responses
Itzchak Levy, Galia Rahav
Current Opinion in HIV and AIDS (2023) Vol. 18, Iss. 3, pp. 135-141
Closed Access | Times Cited: 16

Correlation between CD4 T-Cell Counts and Seroconversion among COVID-19 Vaccinated Patients with HIV: A Meta-Analysis
Qian Zhou, Yihuang Liu, Furong Zeng, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 789-789
Open Access | Times Cited: 16

Determinants of COVID-19 Vaccine Uptake Among People Living with Human Immunodeficiency Virus
Gaukhar Mergenova, Alissa Davis, Susan L. Rosenthal, et al.
Journal of the International Association of Providers of AIDS Care (JIAPAC) (2025) Vol. 24
Open Access

Humoral immune response to two doses of COVID‐19 mRNA‐based vaccines in people living with HIV: A systematic review and meta‐analysis
Negin Farhadian, Sara Sharifi, Mahdi Taghadosi, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 4
Closed Access | Times Cited: 7

Effectiveness of vaccination against SARS-CoV-2 and the need for alternative preventative approaches in immunocompromised individuals: a narrative review of systematic reviews
Thuan Tong Tan, Heng Joo Ng, Barnaby Edward Young, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 341-365
Open Access | Times Cited: 6

Immunogenicity and effectiveness of COVID-19 booster vaccination among people living with HIV: a systematic review and meta-analysis
Meng-Qun Cheng, Rong Li, Zhiying Weng, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 6

Pre-existing cell populations with cytotoxic activity against SARS-CoV-2 in people with HIV and normal CD4/CD8 ratio previously unexposed to the virus
Guiomar Casado-Fernández, Juan Cantón, Laura Nasarre, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2

SARS‐CoV‐2 vaccine immunogenicity for people living with HIV: A systematic review and meta‐analysis
Mads Herluf Søndergaard, Jannifer Jasmin Thavarajah, Henry Henson, et al.
HIV Medicine (2023) Vol. 25, Iss. 1, pp. 16-37
Open Access | Times Cited: 5

Safety and Immunogenicity of the Inactivated COVID-19 Vaccine Booster in People Living with HIV in China
Yunyun Yi, Xiaoxu Han, Xinyu Cui, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1019-1019
Open Access | Times Cited: 3

Immunogenicity and safety of COVID-19 vaccines among people living with HIV: A systematic review and meta-analysis
Tian-Yu Zhao, Zongxing Yang, Yuxia Wu, et al.
Epidemiology and Infection (2023) Vol. 151
Open Access | Times Cited: 3

Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2)
Alexandra Griessbach, Frédérique Chammartin, Irène A. Abela, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 11
Open Access | Times Cited: 3

The Interrelationship between HIV Infection and COVID-19: A Review of the Literature
Yiyu Wang, Yu Lai
Current HIV Research (2023) Vol. 22, Iss. 1, pp. 6-15
Closed Access | Times Cited: 1

Humoral response 24 months after the first COVID-19 vaccination in people with HIV with and without diabetes
Louise Bering, Line Dam Heftdal, Safura-Luise Heidari, et al.
AIDS (2024) Vol. 38, Iss. 15, pp. 2100-2103
Closed Access

COVID-19 Vaccine Safety Studies among Vulnerable Populations: A Systematic Review and Meta-analysis of 120 Observational Studies and Randomized Clinical Trials
Sima Mohammadi, Malede Mequanent Sisay, Putri Widi Saraswati, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Characterization of Immunogenicity and Safety of COVID-19 mRNA-1273 in HIV-Positive Italian Patients with Hemophilia: A Prospective Single-Center Cohort Study
Chiara Suffritti, Roberta Gualtierotti, Sara Arcudi, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 17, pp. 5475-5475
Open Access | Times Cited: 1

Factors associated with SARS-CoV-2 infection among people living with HIV: Data from the Balearic cohort (EVHIA)
Francisca Artigues Serra, Sophia Pinecki Socias, Francisco Fanjul, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0308568-e0308568
Open Access

Immunogenicity and Determinants of Antibody Response to the BNT162b2 mRNA Vaccine: A Longitudinal Study in a Cohort of People Living with HIV
Tatjana Baldovin, Davide Leoni, Ruggero Geppini, et al.
Vaccines (2024) Vol. 12, Iss. 10, pp. 1172-1172
Open Access

Patients under medical conditions, immunogenicity and safety of covid-19 vaccines: a systematic review and meta-analysis
Attapon Cheepsattayakorn
Journal of Lung Pulmonary & Respiratory Research (2023) Vol. 10, Iss. 1, pp. 18-21
Open Access

Safety profiles of homologous and heterologous regimens containing three major types of COVID-19 vaccine among people living with HIV
Thana Khawcharoenporn, Sirashat Hanvivattanakul
International Journal of STD & AIDS (2023) Vol. 35, Iss. 4, pp. 262-273
Closed Access

Page 1

Scroll to top